Literature DB >> 16678487

Fine-tuning leukocyte responses: towards a chemokine 'interactome'.

Christian Weber1, Rory R Koenen.   

Abstract

The extended family of chemokines regulates the activation of leukocytes and coordinates their trafficking to sites of inflammation and during immune surveillance. The heptahelical-receptor-binding and function of chemokines is thought to be governed by their interaction with cell surface proteoglycans, oligomer formation, naturally occurring antagonists and proteolytic processing. Recent studies reveal that heterophilic interactions between chemokines can significantly modify their biological activities and through these we can gain initial insights into the structural basis underlying this novel regulatory mechanism. Here, we propose the concept of a functional 'interactome', constituted by a variety of heterophilic chemokine-chemokine interactions in particular microenvironments. This model could establish how signals conferred by various chemokines are integrated for the combinatorial control of leukocyte responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678487     DOI: 10.1016/j.it.2006.04.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  29 in total

1.  An integrated stochastic model of "inside-out" integrin activation and selective T-lymphocyte recruitment.

Authors:  Michael T Beste; Dooyoung Lee; Michael R King; Gary A Koretzky; Daniel A Hammer
Journal:  Langmuir       Date:  2012-01-04       Impact factor: 3.882

Review 2.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 3.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

4.  A functional heteromeric MIF receptor formed by CD74 and CXCR4.

Authors:  Verena Schwartz; Hongqi Lue; Sandra Kraemer; Joanna Korbiel; Regina Krohn; Kim Ohl; Richard Bucala; Christian Weber; Jürgen Bernhagen
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

5.  Comprehensive assessment of chemokine expression profiles by flow cytometry.

Authors:  Jens Eberlein; Tom T Nguyen; Francisco Victorino; Lucy Golden-Mason; Hugo R Rosen; Dirk Homann
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

6.  Platelets in early antibody-mediated rejection of renal transplants.

Authors:  Hsiao-Hsuan Kuo; Ran Fan; Nina Dvorina; Andres Chiesa-Vottero; William M Baldwin
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

Review 7.  Myeloid cell trafficking and tumor angiogenesis.

Authors:  Michael C Schmid; Judith A Varner
Journal:  Cancer Lett       Date:  2006-10-17       Impact factor: 8.679

Review 8.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

9.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

Review 10.  Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans.

Authors:  Tiziana Adage; Anna-Maria Piccinini; Angelika Falsone; Martin Trinker; James Robinson; Bernd Gesslbauer; Andreas J Kungl
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.